The Serbian government, alongside Russia’s State Atomic Energy Corporation Rosatom, are set to build a new centre for nuclear science and technology in Serbia.
Credit: Rosatom
The Serbian government and Rosatom signed an agreement to form a joint venture that will implement the project in Serbia.
Read more: Russia invests in €2bn Baltic port extension
Under the agreements, a Nuclear Medicine Centre with a cyclotron complex and radio-pharmaceuticals production facilities will be built in Serbia within the next three years.
The CNST will incorporate a cyclotron complex and radiopharmaceutical production facilities and will produce radioactive isotopes for use in both medicine and industry. It will also manufacture doped silicon for use in various industries, and carry out material composition tests of ores, minerals, and environmental samples.
"We are very happy that, together with our Serbian partners, we have identified the specific steps and a preliminary timeline for implementing this project, which employs Russian innovative nuclear technologies," said Alexey Likhachev, Rosatom’s Director-General.
"The radio-pharmaceutical complex and the nuclear medicine centre will provide Serbian citizens with high-tech medical solutions to treat, above all, oncology conditions",
Rosatom holds a 17% share of the global nuclear fuel market and is the largest producer of electricity in Russia. The company has previously supported the construction of 150 nuclear research facilities and 22 other CNST projects for scientific technology applications around the world, in countries including the Czech Republic, Hungary, Egypt, Poland, Kazakhstan, Uzbekistan and Vietnam.
Read more: Jacobs wins two Czech nuclear waste management contracts
Described as a “historic day in the relations between Serbia and Russia”, the agreements were signed following a meeting between Serbian President Aleksandar Vučić and Russian President Vladimir Putin.
Back to Homepage
Back to Energy & Utilities